#pharmaceutical-innovation

[ follow ]
#diabetes
fromFuturism
1 week ago
Alternative medicine

Human Experiments on GLP-1 Pill Looking Extremely Promising

A new oral drug, orforglipron, offers a promising alternative to GLP-1 injections for diabetes and weight loss.
fromNature
6 months ago
Medicine

Glucose-sensitive insulin with attenuation of hypoglycaemia - Nature

The quest for glucose-responsive insulin seeks to prevent hypoglycaemia while maintaining optimal glucose control.
Engineering glucose-responsive properties in insulin itself offers a promising alternative to existing methods for diabetes management.
fromBusiness Insider
4 months ago
Miscellaneous

I'm the Danish scientist who pioneered injectable drugs like Ozempic. Here are my 3 tips for inventing blockbuster products.

Lotte Bjerre Knudsen's research was pivotal in transforming short-acting GLP-1 hormones into successful long-acting diabetes treatments like Ozempic.
Alternative medicine
fromFuturism
1 week ago

Human Experiments on GLP-1 Pill Looking Extremely Promising

A new oral drug, orforglipron, offers a promising alternative to GLP-1 injections for diabetes and weight loss.
fromNature
6 months ago
Medicine

Glucose-sensitive insulin with attenuation of hypoglycaemia - Nature

The quest for glucose-responsive insulin seeks to prevent hypoglycaemia while maintaining optimal glucose control.
Engineering glucose-responsive properties in insulin itself offers a promising alternative to existing methods for diabetes management.
fromBusiness Insider
4 months ago
Miscellaneous

I'm the Danish scientist who pioneered injectable drugs like Ozempic. Here are my 3 tips for inventing blockbuster products.

Lotte Bjerre Knudsen's research was pivotal in transforming short-acting GLP-1 hormones into successful long-acting diabetes treatments like Ozempic.
more#diabetes
fromSilicon Canals
3 weeks ago
OMG science

Luxembourg's Exobiosphere raises 2M to accelerate drug discovery in space; here's why and how - Silicon Canals

Exobiosphere raises €2M seed funding for space-based drug discovery research using autonomous lab automation.
Medicine
fromFast Company
2 months ago

FDA approves non-opioid painkiller designed to eliminate risk of addiction

Vertex has received FDA approval for Journavx, a pain medication designed to mitigate addiction and overdose risks typically associated with opioids.
[ Load more ]